Root extracts of Anacardium occidentale reduce hyperglycemia and oxidative stress in vitro

Abstract

Background Hyperglycemia is the hallmark of diabetes, and the associated oxidative stress is a major concern that invites an array of diabetic complications. The traditional practices of medicare are of great, current interest due to the high cost and side effects of conventional diabetic medications. The present in vitro study focuses on evaluating the potential of various A. occidentale root extracts for their antihyperglycemic and antioxidant potentials. Materials and methods The four different solvent extracts petroleum ether (PEAO), chloroform (CHAO), ethyl acetate (EAAO), and 80 % methanol (80 % MAO) of A. occidentale roots were evaluated for their total phenolic, flavonoid, and antioxidant capacity. Using MIN6 pancreatic β-cells, the cytotoxicity of the extracts was evaluated by MTT assay and the antidiabetic potential by quantifying the insulin levels by ELISA at a higher concentration of glucose. The effect of 80 % MAO on INS gene expression was determined by qRT PCR analysis. Results Among the four different solvent extracts of A. occidentale roots, 80 % MAO showed the highest concentration of phenolics (437.33 ± 0.03 µg GAE/mg), CHAO to be a rich source of flavonoids (46.04 ± 0.1 µg QE/mg) and with the highest total antioxidant capacity (1865.33 ± 0.09 µg AAE/ mg). Evaluation of the free radical scavenging and reducing properties of the extracts indicated 80 % MAO to exhibit the highest activity. The MTT assay revealed the least cytotoxicity of all four extracts. 80 % MAO enhanced INS up-regulation as well as insulin secretion even under high glucose concentration (27mM). Conclusions The present study demonstrated that the A. occidentale root extracts have effective antihyperglycemic and antioxidative properties, together with the potential of normalizing the insulin secretory system of β-cells. Above mentioned properties have to be studied further by identifying the active principles of A. occidentale root extracts and in vivo effects. The prospect of the present study is identifying drug leads for better management of diabetes from the A. occidentale root extracts. Graphical abstract

In silico profiling of analgesic and antihyperglycemic effects of ethanolic leaves extract of Amischotolype mollissima: Evidence from in vivo studies

“…reactive chemical species, noticeably hydroxyl radicals and superoxide ions ( Majeed et al, 2021 ). Hence, it has now become important to identify natural antioxidants to combat a variety of physiological issues such as diabetes mellitus ( Archana et al, 2021 ), atherosclerosis, chronic renal failure, cancer and immune dysfunction ( Souri et al, 2010 ) as well as neurodegenerative diseases. As medicinal plants contain a mixture of chemical compounds, they are now considered an easily available and potent source of antioxidants ( Saiah et al, 2016 ).…”

Ethnomedicinal Knowledge of Plants Used in Nonconventional Medicine in the Management of Diabetes Mellitus in Kinshasa (Democratic Republic of the Congo)

“…Lv [17] In vivo rat: 200-600 mg/kg [18] Aloe succotrina Weston V 1.53 Asphodelaceae Langa Ngwaka Lv [19] In vivo rat: 100-200 mg/kg [20] Anacardium occidentale L. X 0.92 Anacardiaceae Nkasu Kongo Ro [21] In vitro: 12.5 µg/mL [22] Lv [23] In vivo rat: 100 mg/kg [24] Sb In vivo rat: 200 mg/kg [25] Annona senegalensis Pers. W…”

The Analysis of Artabotrys hexapetalus Stem Bark and Leaf Ethanol Extract as α-Glucosidase Inhibitor in Relation to Antioxidant Activity, Phenolic, and Flavonoid Contents Using In Vitro Analysis, LC-MS, Machine Learning and Molecular Docking

“…This condition also decreases antioxidative enzymes in the pancreatic cells, making those cells more susceptible to oxidative stress. To help the pancreatic cells from deteriorating, an exogenous antioxidant agent is needed (Archana et al 2021). Therefore, it is very useful if one compound has both antioxidant and antidiabetic to help curing the T2D patient.…”